Today: 1 February 2026
Subscribe
Browse Category

NASDAQ:BIIB News 20 December 2025 - 22 December 2025

Biogen (BIIB) Stock News Today (Dec. 22, 2025): QALSODY Data, Nasdaq-100 Exit, and Analyst Forecasts

Biogen (BIIB) Stock News Today (Dec. 22, 2025): QALSODY Data, Nasdaq-100 Exit, and Analyst Forecasts

Biogen Inc. (NASDAQ: BIIB) is in focus on Monday, December 22, 2025—a day that combines company-specific clinical headlines with a major index event for the stock. Investors are weighing fresh long‑term data for QALSODY (tofersen) in a rare genetic form of ALS, Biogen’s public statement honoring co‑founder Charles Weissmann, and the market mechanics of Biogen’s removal from the Nasdaq‑100, which…
22 December 2025
·····
Biogen Stock Forecast for the Week Ahead (Dec. 22–26, 2025): BIIB Near 52-Week High as Leqembi Momentum Meets an Analyst Split

Biogen Stock Forecast for the Week Ahead (Dec. 22–26, 2025): BIIB Near 52-Week High as Leqembi Momentum Meets an Analyst Split

Biogen Inc. (NASDAQ: BIIB) heads into the Christmas week with its stock hovering just below a recent high, a fresh spike in trading volume, and a narrative that’s increasingly dominated by one question: can the company turn Leqembi’s momentum into a durable growth engine while legacy revenue lines mature and competition intensifies? As of Sunday, December 21, 2025, BIIB is…
21 December 2025
····
Biogen Stock (NASDAQ: BIIB) News and Forecasts for Dec. 20, 2025: RBC’s $210 Target, Leqembi Catalysts, and What Investors Are Watching

Biogen Stock (NASDAQ: BIIB) News and Forecasts for Dec. 20, 2025: RBC’s $210 Target, Leqembi Catalysts, and What Investors Are Watching

Biogen Inc. stock (NASDAQ: BIIB) is ending the week on a stronger note after a sharp, high-volume move on Friday’s session—an attention-grabbing setup heading into late December when liquidity often thins and headlines can move shares quickly. As of Saturday, December 20, 2025 (with U.S. markets closed), BIIB is effectively reflecting Friday, Dec. 19’s close of $174.80, up 2.88% on…
20 December 2025
·····
Biogen Stock (BIIB) After-Hours on Dec. 19, 2025: Why Shares Jumped, Where They Closed After the Bell, and What to Watch Before the Next Market Open

Biogen Stock (BIIB) After-Hours on Dec. 19, 2025: Why Shares Jumped, Where They Closed After the Bell, and What to Watch Before the Next Market Open

Biogen Inc. (NASDAQ: BIIB) finished Friday, December 19, 2025 with a strong gain and unusually heavy trading volume, then edged higher in extended trading—capping a session dominated by fresh analyst commentary and renewed attention on the company’s Alzheimer’s and pipeline narrative. BIIB shares rose 2.88% to close at $174.80 in regular trading, with volume jumping to roughly 15 million shares,…
20 December 2025
····

Stock Market Today

  • Euronext Stock Sees Quiet Rally Amid Earnings and Strategic Focus
    February 1, 2026, 7:18 AM EST. Euronext's stock has quietly outperformed many European financial stocks, benefiting from increased listings, data ambitions, and strict cost management. Investors face a choice: view the exchange giant as a late-cycle safe haven or a value trap. Over the past year, Euronext's share price delivered solid double-digit returns, supported by shareholder payouts and steady earnings amid a cautious market. Recent quarterly earnings revealed a resilient top line, driven by stable cash-equity trading revenue and active listing activity. The outlook now hinges on whether continued earnings growth and structural shifts in European equity culture can push the stock into a meaningful breakout or if it will consolidate as expectations catch up with reality.
Go toTop